Our work uncovers a role for SETD2 in constraining mitochondrial OXPHOS and mTORC1 signaling to limit cellular proliferation in the context of KRAS-driven lung adenocarcinoma. This evidence concerns the gene KRAS and lung adenocarcinoma.